Research progress on the role of PTEN deletion or mutation in the immune microenvironment of glioblastoma

被引:1
|
作者
Du, Leiya [1 ]
Zhang, Qian [1 ]
Li, Yi [1 ]
Li, Ting [1 ]
Deng, Qingshan [2 ]
Jia, Yuming [1 ]
Lei, Kaijian [1 ]
Kan, Daohong [3 ]
Xie, Fang [1 ]
Huang, Shenglan [1 ]
机构
[1] Second Peoples Hosp Yibin, Dept Oncol, Yibin, Sichuan, Peoples R China
[2] Second Peoples Hosp Yibin, Dept Neurosurg, Yibin, Sichuan, Peoples R China
[3] Second Peoples Hosp Yibin, Dept Burn & Plast Surg, Yibin, Sichuan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
glioblastoma; PTEN; immunity; tumor microenvironment; immunosuppressive; TUMOR-SUPPRESSOR PTEN; MYELOID CELLS; NUCLEAR PTEN; CROSS-TALK; AUTOPHAGY; GLIOMA; IMMUNOTHERAPY; EXPRESSION; MACROPHAGES; MICROGLIA;
D O I
10.3389/fonc.2024.1409519
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent advances in immunotherapy represent a breakthrough in solid tumor treatment but the existing data indicate that immunotherapy is not effective in improving the survival time of patients with glioblastoma. The tumor microenvironment (TME) exerts a series of inhibitory effects on immune effector cells, which limits the clinical application of immunotherapy. Growing evidence shows that phosphate and tension homology deleted on chromosome ten (PTEN) plays an essential role in TME immunosuppression of glioblastoma. Emerging evidence also indicates that targeting PTEN can improve the anti-tumor immunity in TME and enhance the immunotherapy effect, highlighting the potential of PTEN as a promising therapeutic target. This review summarizes the function and specific upstream and downstream targets of PTEN-associated immune cells in glioblastoma TME, providing potential drug targets and therapeutic options for glioblastoma.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
    Schalper, Kurt A.
    Rodriguez-Ruiz, Maria E.
    Diez-Valle, Ricardo
    Lopez-Janeiro, Alvaro
    Porciuncula, Angelo
    Idoate, Miguel A.
    Inoges, Susana
    De Andrea, Carlos
    Lopez-Diaz de Cerio, Ascension
    Tejada, Sonia
    Berraondo, Pedro
    Villarroel-Espindola, Franz
    Choi, Jungmin
    Gurpide, Alfonso
    Giraldez, Miriam
    Goicoechea, Iosune
    Gallego Perez-Larraya, Jaime
    Sanmamed, Miguel F.
    Perez-Gracia, Jose L.
    Melero, Ignacio
    NATURE MEDICINE, 2019, 25 (03) : 470 - +
  • [42] SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment
    Snacel-Fazy, Emmanuel
    Souberan, Aurelie
    Grange, Magali
    Joseph, Kevin
    Colin, Carole
    Morando, Philippe
    Luche, Herve
    Pagano, Alessandra
    Brustlein, Sophie
    Debarbieux, Franck
    Toutain, Soline
    Siret, Carole
    van de Pavert, Serge A.
    Rougon, Genevieve
    Figarella-Branger, Dominique
    Ravi, Vidhya Madapusi
    Tabouret, Emeline
    Tchoghandjian, Aurelie
    CELL DEATH & DISEASE, 2024, 15 (09):
  • [43] Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment
    Wei, Jun
    Gilboa, Eli
    Calin, George A.
    Heimberger, Amy B.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] The role of innate immune cells in the colorectal cancer tumor microenvironment and advances in anti-tumor therapy research
    Liu, Wenxuan
    Kuang, Tianrui
    Liu, Li
    Deng, Wenhong
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [45] Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
    Zhang, Na
    Wei, Li
    Ye, Meng
    Kang, Chunsheng
    You, Hua
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [46] Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells
    Moura, Tania
    Laranjeira, Paula
    Caramelo, Olga
    Gil, Ana M.
    Paiva, Artur
    CURRENT ONCOLOGY, 2025, 32 (03)
  • [47] The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment
    Li, Mengyuan
    Jiang, Ping
    Yang, Yuhan
    Xiong, Liting
    Wei, Shuhua
    Wang, Junjie
    Li, Chunxiao
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [48] Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis
    Zhang, Haofuzi
    Bao, Mingdong
    Liao, Dan
    Zhang, Zhuoyuan
    Tian, Zhicheng
    Yang, Erwan
    Luo, Peng
    Jiang, Xiaofan
    MEDICAL ONCOLOGY, 2023, 40 (06)
  • [49] Progress in the Regulation of Immune Cells in the Tumor Microenvironment by Bioactive Compounds of Traditional Chinese Medicine
    Chen, Yuqian
    Fan, Wenshuang
    Zhao, Yanyan
    Liu, Meijun
    Zhang, Weifen
    Hu, Linlin
    MOLECULES, 2024, 29 (10):
  • [50] Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges
    Lu, Jie
    Huo, Wen
    Ma, Yingze
    Wang, Xin
    Yu, Jinming
    CANCER LETTERS, 2024, 600